BEAM OTOLOG KÖK HÜCRE NAKLİ HAZIRLIK PROTOKOLÜ

Kaynaklar:

1-Buadi F. K, Micallef I. N, Ansell S. M, et al. 2006.''Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma'.Bone Marrow Transplantation 37 (11), 1017–1022.

2-Salar A, Sierra J, Gandarillas M et al. 2001"Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens" Bone Marrow Transplant. Feb;27(4):405-12.

3-Chopra, R., A. K. McMillan, D. C. Linch, et al. 1993. "The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients." Blood. 81(5):1137-1145.

4-Mills, W., R. Chopra, A. McMillan, et al. 1995. "BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma." J Clin Oncol 13(3):588-595.

5-Linch, DC, AH Goldstone, A McMillan, et al 1993. "Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial." The Lancet 341(8852):1051-1054.

6-William, B. M., F. R. Loberiza, Jr., V. Whalen, et al. 2013. "Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma." Clin Lymphoma Myeloma Leuk 13(4):417-423.

7-Schmitz, N., B. Pfistner, M. Sextro, et al. 2002. "Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial." Lancet 359(9323):2065-2071.

8-Philip, T, C Guglielmi, A Hagenbeek, et al. 1995. "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma." New England Journal of Medicine 333(23):1540.

9-Puig, N., De La Rubia, J., Remigia M, et al. 2006. "Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation." Leukemia and Lymphoma. Aug;47(8):1488-94.

10-Apperley J, Carreras E, Gluckman E, et al. Haematopoietic Stem Cell Transplantation: The ESH-EBMT Handbook. Fifth Edition. Forum Service Editore, Genoa.